Can Ozempic cause personality changes​ or depression?
Ozempic (semaglutide) is a GLP-1 receptor agonist primarily prescribed for type 2 diabetes and, off-label, for weight loss. Recently, there have been reports and discussions about whether Ozempic can cause personality changes or depression. While there have been case reports and anecdotal evidence on social media, the majority of scientific reviews have not found an association between Ozempic and suicidal thoughts or actions.
Can Ozempic Cause Depression?
The question, "Can Ozempic cause depression?" is gaining attention as users and healthcare providers report mood-related side effects. Scientific evidence suggests that while some individuals may experience changes in mood or personality, these effects are not universal.
Most reports are observational, and there is currently no definitive proof that Ozempic directly causes depression. However, the drug’s influence on brain pathways involved in reward and mood regulation raises concerns, especially for people with pre-existing mental health conditions. Patients should consult their healthcare providers to monitor any emotional or behavioral changes during treatment, ensuring prompt management if needed.
Evidence on Personality Changes and Depression From Ozempic
Mood changes, such as depression, are not mentioned as common side effects in the manufacturer labeling for Ozempic. Interestingly, there is a warning about suicidal behavior and ideation in the Wegovy package insert (another brand name for semaglutide approved for weight loss), but it is based on reports of this side effect with other weight management products.
Regulatory agencies like the FDA and EMA have closely examined safety data related to Ozempic, including thousands of adverse event reports submitted through systems like the FDA’s Adverse Event Reporting System (FAERS). While reports of depression, mood changes, and even suicidal ideation have been documented, these do not confirm a direct cause-and-effect relationship. Ongoing investigations by the FDA and the European Medicines Agency continue to assess whether there is a true causal relationship.
Below is a summary of research on mood changes from Ozempic:
- One study revealed that users have reported anxiety, depression, and other mental health problems related to Ozempic on social media platforms. Some describe these effects as "Ozempic personality," even though the term is not scientifically established.
- A 2024 cohort study revealed that patients taking GLP-1 drugs had a higher risk of depression, anxiety, and suicidal behavior compared to patients not taking these medications.
- The FDA acknowledges reports of new or worsening depression, suicidal thoughts, or unusual mood changes in patients taking GLP-1 drugs and advises patients to seek medical attention if these occur. So far in their review, they have not found evidence that GLP-1 drugs like Ozempic cause suicidal thoughts or actions. Monitoring by the FDA is ongoing.
- A recent 12-month study found no increased risk of adverse neuropsychiatric outcomes with semaglutide compared to other diabetes medications.
- A 2024 post hoc analysis of the STEP 1, 2, 3, and 5 clinical trials showed that patients with obesity or overweight who took semaglutide were not at a higher risk for developing depression or suicidal thoughts/behavior compared to placebo.
- In 2024, the EMA has stated that available evidence does not indicate a causal association between GLP-1 agonists like semaglutide and suicidal thoughts or actions. This was following a review of electronic health records and other available evidence from different studies.
- An analysis of the World Health Organization Vigibase revealed more reports of suicidal thoughts by people taking semaglutide compared to other diabetes medications. However, this was more common in people already taking medications to treat anxiety or depression.
Related questions
- Mounjaro vs Ozempic: Which is right for you?
- Ozempic Side Effects to Watch For
- What are the long-term side effects of Ozempic?
How Ozempic Affects Your Brain
Understanding why Ozempic might cause mood changes requires looking at how this diabetes medication actually reaches and affects your brain. Unlike smaller drugs that can easily cross the protective barrier around your brain, semaglutide (the active ingredient in Ozempic) is a large molecule that doesn't appear to get through normal brain barriers.
Instead, Ozempic accesses your brain through special "gateway" regions that don't have complete protective barriers. These areas, including parts of your brainstem and hypothalamus, allow larger molecules to enter. Once there, specialized cells called tanycytes act like shuttles, transporting the medication deeper into brain regions that control mood, appetite, and behavior.
Once in your brain, Ozempic activates receptors that are normally triggered by a hormone called GLP-1, which your body naturally produces in your intestines and brain. These same brain regions that Ozempic targets are also involved in regulating your mood, motivation, and emotional responses. When Ozempic changes how these areas function, it can inadvertently affect how you feel emotionally, not just how hungry you are.
Why Some People Experience Ozempic Personality Changes and Mood Swings
Many people report feeling "different" on Ozempic, such as being less interested in activities they used to enjoy, changes in their social behavior, or shifts in their emotional responses. These personality changes may be linked to how Ozempic affects your brain's reward system, the network of brain regions that controls motivation and pleasure. Your brain's reward system relies heavily on a chemical called dopamine, which makes you feel good when you do something enjoyable. Examples include eating your favorite food, spending time with friends, or pursuing a hobby.
Ozempic appears to change how this dopamine system functions, potentially making it less responsive to things that used to bring you pleasure. However, more studies are needed to confirm the relationship and mechanisms behind Ozempic and personality changes.
When to Get Medical Help
Monitor mood and behavior closely when starting Ozempic, and report any new or worsening depression, anxiety, or unusual mood changes to a healthcare professional immediately. Warning signs that warrant immediate medical attention include:
- Persistent feelings of sadness or hopelessness
- Loss of interest in activities you previously enjoyed
- Significant changes in sleep patterns or appetite beyond what's expected from the medication
- Increased anxiety, panic attacks, or feelings of restlessness
- Thoughts of self-harm or suicide
- Dramatic personality changes that concern you or your loved ones
- Difficulty concentrating or making decisions
- Social withdrawal or isolation
Do not discontinue Ozempic without medical advice, as untreated diabetes or obesity can also impact mental health.
Summary
While some patients taking Ozempic report mood changes, anxiety, or depressive symptoms that they interpret as personality changes, these effects are not widely documented in clinical trials or official prescribing information. Large-scale studies have not confirmed a direct causal link. Patients experiencing mood changes should promptly discuss these symptoms with their healthcare provider to ensure appropriate management.
References
- Arillotta, D., et. al. 2023. GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain sciences, 13(11), 1503. https://doi.org/10.3390/brainsci13111503
- Daniels, D., & Mietlicki-Baase, E. G. (2019). Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?. Diabetes, 68(1), 15–17. https://doi.org/10.2337/dbi18-0045
- De Giorgi, R., et. al. 2024. 12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study. In: The Lancet. DOI: https://doi.org/10.1016/j.eclinm.2024.102726
- Dong, M., Wen, S., & Zhou, L. (2022). The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors. Diabetes, metabolic syndrome and obesity : targets and therapy, 15, 2583–2597. https://doi.org/10.2147/DMSO.S375559
- European Medicines Agency. 2024. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024. Accessed on May 7, 2025 at https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-2024
- Kornelius, E., Huang, J. Y., Lo, S. C., Huang, C. N., & Yang, Y. S. (2024). The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy. Scientific reports, 14(1), 24433. https://doi.org/10.1038/s41598-024-75965-2
- Li, J. R., et. al. 2023. Case Report: Semaglutide-associated depression: a report of two cases. Frontiers in psychiatry, 14, 1238353. https://doi.org/10.3389/fpsyt.2023.1238353
- Manoharan, S. V. R. R., et. al. 2024. GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide). Innovations in clinical neuroscience, 21(4-6), 25–26. PMCID: PMC11208009 PMID: 38938530
- Ozempic [package insert]. Updated 2025. Novo Nordisk. Accessed on May 6, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Schoretsanitis, G., et al. 2024. Disproportionality analysis from World Health Organization Data on semaglutide, liraglutide, and suicidality. JAMA Network Open. DOI: https://doi.org/10.1001/jamanetworkopen.2024.23385
- US Food and Drug Administration. 2024. Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity. Accessed on May 7, 2025 at https://www.fda.gov/drugs/drug-safety-and-availability/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type
- Wadden, T. A., Brown, G. K., Egebjerg, C., Frenkel, O., Goldman, B., Kushner, R. F., McGowan, B., Overvad, M., & Fink-Jensen, A. (2024). Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials. JAMA internal medicine, 184(11), 1290–1300. https://doi.org/10.1001/jamainternmed.2024.4346
- Wang, W., et. al. 2024. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat Med. 2024 Jan;30(1):168-176. DOI: https://doi.org/10.1038/s41591-023-02672-2
Read next
Ozempic Mounjaro Wegovy & Zepbound: Weight Loss Compared
Ozempic, Mounjaro, Wegovy and Zepbound can all lead to long-term weight loss, but only Wegovy and Zepbound are approved by the FDA for this use. In studies, Zepbound has led to a 21% weight loss in adults using the highest dose, while Wegovy has led to about a 15% weight loss.
Continue reading
Wegovy vs Ozempic: Which is Right for You?
Both Wegovy and Ozempic contain semaglutide, but Wegovy is prescribed for long-term weight management while Ozempic is used to control blood sugar levels in type 2 diabetes and help protect kidney function. They both lower the risk for heart-related complications, but they differ in other approved uses, doses, target populations and costs.
Continue reading
How long does it take for Ozempic to work?
Your blood glucose (sugar) levels should start to fully decline within the first week after you start using Ozempic (semaglutide) at your regular dose. However, the full effect can take 8 weeks or longer, as this is a long-acting medication that is injected only once per week. Continue reading
See also:
Related medical questions
- How many doses are in an Ozempic pen?
- Which GLP-1 drug is best for weight loss?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
- How does Ozempic work for weight loss?
- Can you switch between Ozempic and Mounjaro?
- Does Ozempic need to be refrigerated?
- What happens when you stop taking Ozempic?
- Will my insurance cover the cost of Ozempic?
- Saxenda vs Ozempic: For Weight Loss?
- Can you get tirzepatide from a compounding pharmacy?
- When is the best time of day to take Ozempic?
- Why am I not losing weight on Ozempic?
- Does Ozempic cause muscle loss and how to prevent it?
- Do GLP-1 drugs like Ozempic and Mounjaro cause sulfur burps?
- Are there natural alternatives to Ozempic for weight loss?
- Can you buy Ozempic over the counter?
- Where and how should Ozempic be injected?
- Rybelsus vs Ozempic for weight loss: Which to choose?
- Ozempic Face: What causes it and how to prevent it?
- How long does Ozempic last in your system?
- How long can you stay on Ozempic?
- How does Ozempic affect blood pressure?
- Ozempic and Surgery: When to stop and restart?
Drug information
- Ozempic Information for Consumers
- Ozempic prescribing info & package insert (for Health Professionals)
- Side Effects of Ozempic (detailed)
- Ozempic user reviews (1,602)
Related support groups
- Ozempic (115 questions, 228 members)
- Depression (2,258 questions, 8,797 members)